共 12 条
- [2] 基于网络药理学的罗格列酮复方作用机制探讨[J]. 白雨,范雪梅,孙瀚,王义明,梁琼麟,罗国安.药学学报. 2015(03)
- [6] In vitro screening of inhibition of PPAR-[gamma] activity as a first step in identification of potential breast carcinogens[J] . Kopp,TI,Lundqvist,J,Petersen,RK,Oskarsson,A,Kristiansen,K,Nellemann,C,Vogel,U.Human and Experimental Toxicology . 2015 (11)
- [7] Apatinib for the treatment of gastric cancer [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2015, 16 (01) : 117 - 122
- [8] Multicenter phase II study of apatinib, a novel VEGFR inhibitor in heavily pretreated patients with metastatic triple‐negative breast cancer[J] . Xichun Hu,Jian Zhang,Binghe Xu,Zefei Jiang,Joseph Ragaz,Zhongsheng Tong,Qingyuan Zhang,Xiaojia Wang,Jifeng Feng,Danmei Pang,Minhao Fan,Jin Li,Biyun Wang,Zhonghua Wang,Qunling Zhang,Si Sun,Chunmei Liao.Int. J. Cancer . 2014 (8)
- [9] The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapy[J] . Seung Jin Kim,Norikazu Masuda,Fumine Tsukamoto,Hideo Inaji,Futoshi Akiyama,Hiroshi Sonoo,Junichi Kurebayashi,Katsuhide Yoshidome,Masahiko Tsujimoto,Hiroyuki Takei,Shinobu Masuda,Seigo Nakamura,Shinzaburo Noguchi.Cancer Letters . 2014 (2)